Activating mutations of PI3K and its catalytic subunit alpha (PIK3CA) are associated with co-alterations of PTEN, MAPK and AKT1, which are sufficient to foster tumorigenesis, tumor growth, migration, protein synthesis and glucose metabolism in pre-clinical models [109,110,111,112,113]. This evidence concerns the gene PIK3CG and neoplasm.